Senior Biostatistician
Lindus Health$60,000 - $90,000/year
Full Time
Senior (5 to 8 years), Mid-level (3 to 4 years)
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, Clinical Research, Oncology, Rare DiseasesIndustries
Requirements
- PhD degree in Statistics, Biostatistics, or related field, and 5 years of biostatistical experience in the clinical trials or health research environment OR a Master’s degree in Statistics, Biostatistics, or related field, and 8 years of biostatistical experience in the clinical trials or health research environment
- Excellent written and oral communication skills including grammatical/technical writing skills and familiarity with moderately complex statistical methods that apply to Phase I-IV clinical trials
- Familiarity with SAS, SPSS or other statistical software package
- Proficiency in Microsoft Word and Excel
- Strong level of detail orientation
- Ability to work on multiple tasks under tight timelines
Responsibilities
- Provides statistical input into Phase I - IV clinical trial development
- Performs the analysis of clinical trial data
- Provides statistical input into the reporting of clinical trial results
- Can work independently and function as a lead statistician on clinical trials
Skills
SAS
SPSS
Microsoft Excel
Microsoft Word
Biostatistics
Clinical Trials
Statistical Analysis
Phase I-IV Trials
Statistical Programming
Verisart
Blockchain-based digital certificates for art authentication
About Verisart
Verisart provides digital certificates that authenticate the history and creation of art and collectibles using blockchain technology. Their service allows artists, collectors, galleries, and museums to create secure and tamper-proof records of ownership and provenance. The certificates are generated through a user-friendly platform accessible via mobile devices or computers, requiring only two steps to create museum-quality records. Unlike traditional methods, Verisart's certificates are encrypted and timestamped on a decentralized ledger, ensuring high security and transparency. The company differentiates itself by focusing on the art market and offering a straightforward solution for certificate management. Verisart's goal is to set a global standard for art certification, making records of creation and ownership easily verifiable and protected.
Los Angeles, CaliforniaHeadquarters
2015Year Founded
$4.9MTotal Funding
CONVERTIBLECompany Stage
Crypto & Web3, Consumer GoodsIndustries
1-10Employees
Risks
Blockchain technology evolution may outpace Verisart's current platform capabilities.
Growing competitors like OpenSea could dilute Verisart's market share.
Cryptocurrency market volatility affects Verisart's revenue stability.
Differentiation
Verisart offers patented NFT minting and certification since 2015.
The platform allows creators to choose their blockchain and create smart contracts.
Verisart integrates COA for verifying authenticity of digital and physical art.
Upsides
Increased interest in fractional ownership boosts Verisart's fractionalized NFT offerings.
AI-generated art demand aligns with Verisart's authentication capabilities.
Digital art exhibitions increase need for Verisart's digital certification services.
Related Jobs
RemoteRemoteSenior Clinical Trial Manager
Abata TherapeuticsSalary not specified
- Full Time
- Senior (5 to 8 years)
RemoteClinical Scientist, Clinical Development
Abata TherapeuticsSalary not specified
RemoteSenior Director, Statistical Methodologist
BiogenSalary not specified
- Full Time
- Senior (5 to 8 years)
RemoteDirector, Data and Science (Analytic Solutions)
Verana HealthSalary not specified
- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)